Literature DB >> 12351479

Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

Barbara E K Klein1, Ronald Klein, Kristine E Lee.   

Abstract

OBJECTIVE: To determine whether components of the metabolic syndrome precede the 5-year incidence of cardiovascular disease and diabetes. RESEARCH DESIGN AND METHODS: A population of individuals aged 43-84 years was evaluated from 1988 to 1990 and again 5 years later. Medical history, blood pressure, and laboratory measures were obtained at both examinations following the same protocols. Subjects without diabetes were classified according to level of glycemia, high blood pressure, high-risk lipid levels, high uric acid levels, and proteinuria at baseline. History of incident myocardial infarction, angina, stroke, and diabetes was obtained at follow-up.
RESULTS: Of the 4,423 subjects without diabetes, 6.9% had elevated levels of glycemia, 18.4% had high blood pressure, 82.7% had high-risk lipid levels (either high serum total cholesterol or low HDL cholesterol or high ratio of these two levels), 27% had elevated uric acid levels, 33.2% had high BMI, and 3.3% had proteinuria (> or =30 mg/dl). The risk of incident cardiovascular disease 5 years later increased with the number of the components present; 2.5% of those with one component developed cardiovascular disease, whereas 14.9% of those with four or more components developed cardiovascular disease. Of those with one component, diabetes developed in 1.1% 5 years later, whereas diabetes developed in 17.9% of those with four or more components.
CONCLUSIONS: Components of the metabolic syndrome are common and are associated with incident cardiovascular disease and diabetes after 5 years. Interventions to alter BMI, lipid levels, and blood pressure may decrease incident diabetes and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351479     DOI: 10.2337/diacare.25.10.1790

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  110 in total

1.  Utility of ApoB/ApoA1 ratio for the prediction of cardiovascular risk in children with metabolic syndrome.

Authors:  S Savas Erdeve; E Simsek; Yildiz Dallar; Zeynep Biyikli
Journal:  Indian J Pediatr       Date:  2010-10-06       Impact factor: 1.967

Review 2.  Fibrates for treatment of the metabolic syndrome.

Authors:  Kevin C Maki
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

3.  Association of CD36 gene variants and metabolic syndrome in Iranians.

Authors:  Azita Zadeh-Vakili; Bita Faam; Maryam S Daneshpour; Mehdi Hedayati; Fereidoun Azizi
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-02

Review 4.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

5.  Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.

Authors:  Lauren J Kim; Michael A Nalls; Gudny Eiriksdottir; Sigurdur Sigurdsson; Lenore J Launer; Annemarie Koster; Paulo H M Chaves; Birna Jonsdottir; Melissa Garcia; Vilmundur Gudnason; Tamara B Harris
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

6.  Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.

Authors:  Latisha Love-Gregory; Richard Sherva; Lingwei Sun; Jon Wasson; Timothy Schappe; Alessandro Doria; D C Rao; Steven C Hunt; Samuel Klein; Rosalind J Neuman; M Alan Permutt; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2008-02-27       Impact factor: 6.150

Review 7.  Optimizing management of metabolic syndrome to reduce risk: focus on life-style.

Authors:  Cristina Bianchi; Giuseppe Penno; Giuseppe Daniele; Luca Benzi; Stefano Del Prato; Roberto Miccoli
Journal:  Intern Emerg Med       Date:  2008-02-13       Impact factor: 3.397

Review 8.  SLC2A9--a fructose transporter identified as a novel uric acid transporter.

Authors:  Myphuong T Le; Mohamed Shafiu; Wei Mu; Richard J Johnson
Journal:  Nephrol Dial Transplant       Date:  2008-07-07       Impact factor: 5.992

Review 9.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

10.  Genome-wide linkage analysis of multiple metabolic factors: evidence of genetic heterogeneity.

Authors:  Ching-Yu Cheng; Kristine E Lee; Priya Duggal; Emily L Moore; Alexander F Wilson; Ronald Klein; Joan E Bailey-Wilson; Barbara E K Klein
Journal:  Obesity (Silver Spring)       Date:  2009-05-14       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.